Center-Authored Papers

Filters: Author is Johnson, Karen C  [Clear All Filters]
Journal Article
Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg C, Wactawski-Wende J, Rohan T, O'Sullivan MJ, Yasmeen S, Hiatt RA et al..  2011.  25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.. Maturitas. 68(1):73-8. Abstract
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S et al..  2010.  Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.. Journal of the National Cancer Institute. 102(18):1422-31. Abstract
Carbone LD, Johnson KC, Robbins J, Larson JC, Curb DJ, Watson K, Gass M, LaCroix AZ.  2010.  Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI).. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 25(4):873-81. Abstract
Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J et al..  2009.  Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
Prentice RL, Huang Y, Kuller LH, Tinker LF, Horn LV, Stefanick ML, Sarto G, Ockene J, Johnson KC.  2011.  Biomarker-calibrated energy and protein consumption and cardiovascular disease risk among postmenopausal women.. Epidemiology (Cambridge, Mass.). 22(2):170-9. Abstract
Beasley JM, LaCroix AZ, Larson JC, Huang Y, Neuhouser ML, Tinker LF, Jackson R, Snetselaar L, Johnson KC, Eaton CB et al..  2014.  Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational study.. The American journal of clinical nutrition. 99(4):934-40. Abstract
Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ et al..  2015.  Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.. JAMA oncology. 1(3):296-305. Abstract
Cauley JA, Chlebowski RT, Wactawski-Wende J, Robbins JA, Rodabough RJ, Chen Z, Johnson KC, O'Sullivan MJ, Jackson RD, Manson JE.  2013.  Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.. Journal of women's health (2002). 22(11):915-29. Abstract
Chlebowski RT, Pettinger M, Johnson KC, Wallace R, Womack C, Mossavar-Rahmani Y, Stefanick M, Wactawski-Wende J, Carbone L, Lu B et al..  2013.  Calcium Plus Vitamin D Supplementation and Joint Symptoms in Postmenopausal Women in the Women's Health Initiative Randomized Trial.. Journal of the Academy of Nutrition and Dietetics. 113(10):1302-10. Abstract
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S et al..  2008.  Calcium plus vitamin D supplementation and the risk of breast cancer.. Journal of the National Cancer Institute. 100(22):1581-91. Abstract
Thomson CA, Horn LV, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L et al..  2014.  Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(12):2924-35. Abstract
Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M et al..  2009.  Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.. American journal of epidemiology. 170(4):403-13. Abstract
McTiernan A, Chlebowski RT, Martin C, Peck JD, Aragaki A, Pisano ED, Wang C-Y, Johnson KC, Manson JE, Wallace RB et al..  2009.  Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(36):6135-43. Abstract
Harrington LB, Blondon M, Cushman M, Kaunitz AM, Rossouw JE, Allison MA, Martin LW, Johnson KC, Rosing J, Woods NF et al..  2016.  The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.. Menopause (New York, N.Y.). Abstract
Espeland MA, Pettinger M, Falkner KL, Shumaker SA, Limacher M, Thomas F, Weaver KE, Stefanick ML, McQuellon C, Hunt JR et al..  2013.  Demographic and health factors associated with enrollment in posttrial studies: The women's health initiative hormone therapy trials.. Clinical trials (London, England). Abstract
Arnold M, Jiang L, Stefanick ML, Johnson KC, Lane DS, Leblanc ES, Prentice R, Rohan TE, Snively BM, Vitolins M et al..  2016.  Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States.. PLoS medicine. 13(8):e1002081. Abstract
Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC et al..  2014.  Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial: A Modeling Study.. Annals of internal medicine. 160(9):594-602. Abstract
Schnatz PF, Jiang X, Aragaki AK, Nudy M, OʼSullivan DM, Williams M, Leblanc ES, Martin LW, Manson JE, Shikany JM et al..  2016.  Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.. Obstetrics and gynecology. Abstract
Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J.  2013.  Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial. Menopause: The Journal of The North American Menopause Society. :1.
Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell AF, Mahinbakht A et al..  2015.  Estrogen and colorectal cancer incidence and mortality.. Cancer. Abstract
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE et al..  2010.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.. JAMA : the journal of the American Medical Association. 304(15):1684-92. Abstract
Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C et al..  2013.  Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study.. Journal of the National Cancer Institute. 105(8):526-35. Abstract
Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell AF, Prentice RL.  2012.  Estrogen plus progestin and colorectal cancer incidence and mortality.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(32):3983-90. Abstract
Prentice RL, Mossavar-Rahmani Y, Huang Y, Horn LV, Beresford SAA, Caan B, Tinker L, Schoeller D, Bingham S, Eaton CB et al..  2011.  Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers.. American journal of epidemiology. 174(5):591-603. Abstract
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract